January 25, 2015 5:35 PM ET

Capital Markets

Company Overview of Sofinnova Ventures, Inc.

Executive Profile

Anand Mehra M.D.

General Partner, Sofinnova Ventures, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships


Dr. Anand Mehra, M.D. has been a General Partner at Sofinnova Ventures, Inc. since May 2, 2013. He served as a Partner at the firm. Dr. Mehra joined Sofinnova Ventures in 2007 as a Principal to focus on biopharmaceutical investing. He is focused on working with entrepreneurs to build drug development companies that have the power to improve the lives of patients. His diverse background equips him to work with entrepreneurs on scientific, clinical and strategic levels. ...

Corporate Headquarters

140 Geary Street
San Francisco, California 94108

United States

Phone: 415-228-3380
Fax: 415-228-3390

Board Members Memberships

Director and Member of Compensation Committee
Director and Member of Compensation Committee


Unknown/Other Education
University of Virginia
Columbia University Medical Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sofinnova Ventures, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.